Furthermore, as mentioned above, GNPs are potent antioxidant and anti-inflammatory agents, resulting in quenching ROS, reducing RANKL-induced osteoclast formation and inflammatory cytokines (IL-1, IL-6, and TNF-a) VEGF, which are the main contributors to the RA pathogenesis. This evidence concerns the gene IL6 and rheumatoid arthritis.